Koyfin Home > Directory > Health Care > Aduro Biotech > Total Debt / Equity

Aduro Biotech Total Debt / Equity Chart (ADRO)

Aduro Biotech annual/quarterly Total Debt / Equity from 2013 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Aduro Biotech Total Debt / Equity for the quarter ending June 06, 2020 was $70m a 41.05% increase of 29m year over year
  • Aduro Biotech Total Debt / Equity for the last 12 months ending June 06, 2020 was $70m a 41.05% increase of 29m year over year
  • Aduro Biotech Annual Total Debt / Equity for 2019 was $51m a 494.30% increase of 252m from 2018
  • Aduro Biotech Annual Total Debt / Equity for 2013 was $-201m a 27.94% decrease of -56m from 2012
  • Aduro Biotech Annual Total Debt / Equity for 2012 was $-145m
Other Ratios Metrics:
  • Aduro Biotech Total Debt / Capital for the quarter ending September 09, 2014 was $4m
  • Aduro Biotech Other Liabilities for the quarter ending December 12, 2018 was $192m a 1.13% increase of 2m year over year
View Chart On Koyfin

Quarterly ADRO Total Debt / Equity Data

06/2020$70m
03/2020$55m
12/2019$51m
09/2019$41m
06/2019$34m
03/2019$30m
09/2014$4m
03/2014$-201m
12/2013$-201m

Annual ADRO Total Debt / Equity Data

2019$51m
2013$-201m
2012$-145m